UK government snubs GSK in favour of rival RSV shot from Pfizer
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
The decision is a blow to GSK, which is locked in fierce competition with Pfizer to corner the new market ...
A Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced ...
CONSUMER healthcare firm Haleon said on Monday (Mar 18) that US drugmaker Pfizer, its top shareholder, will sell down its ...
PFIZER’S drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, ...
Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ...
Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to ...
Pfizer CEO Albert Bourla said the purchase of Seagen would help the battle against cancer AFP Pfizer announced Tuesday that it ...
Pfizer reported a third-quarter loss due to a writedown in Covid-19 products AFP Pfizer reported Tuesday a loss following a ...
GSK alleges Pfizer infringed four of its patents in developing a competing RSV vaccine AFP GlaxoSmithKline sued Pfizer on Wednesday ...
Pfizer cited damage to its North Carolina plant as a factor in its lowered 2023 revenue forecast AFP Pfizer reported ...
International Business Weekly is an American entertainment magazine. We cover business News & feature exclusive interviews with many notable figures